-
公开(公告)号:US20220306647A1
公开(公告)日:2022-09-29
申请号:US17607605
申请日:2020-04-29
IPC分类号: C07D498/04 , C07D487/04 , C07D471/04 , C07D471/14
摘要: The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.
-
公开(公告)号:US20220363686A1
公开(公告)日:2022-11-17
申请号:US17290357
申请日:2019-11-01
IPC分类号: C07D487/04 , A61P31/20
摘要: The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.
-
公开(公告)号:US20220081444A1
公开(公告)日:2022-03-17
申请号:US17290347
申请日:2019-11-01
IPC分类号: C07D487/04 , A61P31/20 , C07D519/00
摘要: The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.
-
公开(公告)号:US20210179608A1
公开(公告)日:2021-06-17
申请号:US16760929
申请日:2018-11-02
IPC分类号: C07D471/04
摘要: The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.
-
公开(公告)号:US20220227789A1
公开(公告)日:2022-07-21
申请号:US17607428
申请日:2020-04-29
IPC分类号: C07D519/00 , C07D498/04 , A61P31/20
摘要: The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.
-
公开(公告)号:US20220227785A1
公开(公告)日:2022-07-21
申请号:US17607634
申请日:2020-04-29
IPC分类号: C07D498/04 , C07D487/04 , C07D471/14 , C07D471/04
摘要: The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.
-
-
-
-
-